LIMN
Liminatus Pharma·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
LIMN Filings
Filing Date
Form Description
Form Type
2025-11-25
Form 8-K - Current report
Key Events
2025-11-25 · Key Events
Form 8-K - Current report
2025-11-14
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Financials
2025-11-14 · Financials
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025-10-06
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Financials
2025-10-06 · Financials
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025-08-25
Form 8-K - Current report
Key Events
2025-08-25 · Key Events
Form 8-K - Current report
2025-08-15
Form 3 - Initial statement of beneficial ownership of securities
Ownership
2025-08-15 · Ownership
Form 3 - Initial statement of beneficial ownership of securities
2025-08-15
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB
2025-08-15 ·
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB
2025-08-14
Form 8-K - Current report
Key Events
2025-08-14 · Key Events
Form 8-K - Current report
2025-08-13
Form 424B3 - Prospectus [Rule 424(b)(3)]
2025-08-13 ·
Form 424B3 - Prospectus [Rule 424(b)(3)]
2025-08-13
Form EFFECT - Notice of Effectiveness
2025-08-13 ·
Form EFFECT - Notice of Effectiveness
2025-08-11
Form CORRESP - Correspondence
SEC Inquiries
2025-08-11 · SEC Inquiries
Form CORRESP - Correspondence
